Compare McKesson Corporation (MCK) vs Schwab US Large Cap Growth ETF (SCHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Schwab US Large Cap Growth ETF — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while Schwab US Large Cap Growth ETF trades at $34.25. The key difference: McKesson Corporation pays a 0.39% dividend while Schwab US Large Cap Growth ETF pays none, and Schwab US Large Cap Growth ETF is trading nearer its 52-week high, McKesson Corporation nearer its low. Which is the better fit depends on your goals.
| MCK | SCHG | |
|---|---|---|
Market Cap | $97.35B | — |
Sector | Health | Sector/Thematic |
52-Week High | $995.69 | $35.30 |
52-Week Low | $659.01 | $28.10 |
Enterprise Value | $101.98B | — |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SCHG trades at $34.15, down slightly by 0.09% today, with a bullish technical signal driven by moving averages. The ETF offers concentrated exposure to large-cap U.S. growth stocks, particularly in technology and AI, with a low 0.04% expense ratio. Recent news highlights strong fundamentals and AI-driven growth potential, though heavy concentration in top holdings like Nvidia, Apple, and Microsoft presents both opportunity and risk.
Outlook remains positive for long-term growth investors, supported by AI capital expenditure trends and low costs. Key risks include high valuation sensitivity, interest rate impacts, and lack of diversification. Analyst sentiment is mixed, with some caution on recent underperformance versus broader markets despite strong thematic tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Schwab US Large Cap Growth ETF
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →
